Biotechnology market research reports by DelveInsight

• Microbiome Disease- Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 3,000

  DelveInsight’s, “Microbiome Disease- Pipeline Insight, 2025” report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the thera ... Read More

• AAV Vectors in Gene Therapy- Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 5,000

  DelveInsight’s, “AAV Vectors in Gene Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in AAV Vectors in Gene Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It als ... Read More

• CAR T-cell Therapy - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 3,000

  DelveInsight’s, “CAR T-cell Therapy - Pipeline Insight, 2025” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in CAR T-cell Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More

• Anti-CD152 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD152 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Anti-CD19 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  DelveInsight’s, “Anti-CD19 Antibody - Pipeline Insight, 2025” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Anti-CD19 Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the thera ... Read More

• Anti-CD80 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD80 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Anti GM-CSF Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti GM-CSF Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More

• Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report provides detailed coverage of the pipeline landscape f ... Read More

• Anti-CD28 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD28 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• 20s Proteasome Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “20s Proteasome Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides detailed coverage of the pipeline landscape for thi ... Read More

• Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 5,000

  DelveInsight’s, “Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Chimeric Antigen Receptor T-Cell Therapy (CAR-T) pipeline landscape. It covers the pipeline drug profiles, including cli ... Read More

• Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detailed ... Read More

• Anti-CD33 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD33 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Anti-CD37 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD37 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Anti-CD38 antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  DelveInsight’s, “Anti-CD38 antibody - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More

• Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landscape ... Read More

• Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides detailed coverage of the pipeline l ... Read More

• G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Receptor (GPCR) Agonist development. The report provides detailed coverage ... Read More

• Anti-CD3 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “Anti-CD3 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More

• Anti-CD52 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD52 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Apoptosis Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Apoptosis Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Apoptosis Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Recepto ... Read More

• Antibody Drug Conjugate - Competitive landscape, 2025

  Mar 01, 2025  |  Published by: DelveInsight  |  USD 5,000

  DelveInsight’s, “Antibody Drug Conjugate - Competitive landscape, 2025” report provides comprehensive insights about 180+ companies and 290+ drugs in Antibody Drug Conjugate Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule typ ... Read More

• Anti-CD38 antibody - Pipeline Insight, 2025

  Mar 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  DelveInsight’s, “Anti-CD38 antibody - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More

• Cell and Gene Therapy Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2032

  Feb 01, 2025  |  Published by: DelveInsight  |  USD 3,750

  Cell and Gene Therapy Manufacturing Market by Therapy Type (Cell Therapy [Allogenic and Autologous] and Gene Therapy [Viral Vector-Based Gene Therapy and Non-Viral Vector-Based Gene Therapy]), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), Scale of Manufacturing (Clinical-Scale ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >